Achieve Life Sciences Inc reports results for the quarter ended June 30 - Earnings Summary

• Achieve Life Sciences Inc ACHV reported a quarterly adjusted loss of 37 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of -25 cents. The mean expectation of five analysts for the quarter was for a loss of 36 cents per share. Wall Street expected results to range from -46 cents to -25 cents per share.

• Reported revenue was zero​; analysts expected zero.

• Achieve Life Sciences Inc's reported EPS for the quarter was a loss of 37 cents​.

• The company reported a quarterly loss of $12.72 million.

• Achieve Life Sciences Inc shares had risen by 16.8% this quarter and lost 25.0% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 5.2% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

• Wall Street's median 12-month price target for Achieve Life Sciences Inc is $14.00, about 81.1% above its last closing price of $2.64

This summary was machine generated from LSEG data August 7 at 05:27 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)